2.5 mg Linagliptin ""'

Linagliptin 2.5 mg
LINALIGLIP is a medication used for the management of type 2 diabetes mellitus. LINALIGLIP is classified as a dipeptidyl peptidase-4 (DPP-4) inhibitor, which is a class of drugs that help regulate blood sugar levels by preventing the breakdown of incretin hormones like GLP-1 (glucagon-like peptide-1). GLP-1 plays a role in stimulating insulin secretion and reducing glucagon release, both of which help control blood glucose levels.
LINALIGLIP works by inhibiting the enzyme DPP-4, which is responsible for breaking down GLP-1. By inhibiting DPP-4, LINALIGLIP increases the levels of active GLP-1 in the body, which enhances insulin secretion and reduces glucagon release, ultimately leading to improved blood sugar control.
LINALIGLIP is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
LINALIGLIP is available in strengths of 2.5 and 5 mg .
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/linaliglip-2-5-134280